(Q35951523)

11 August 2017

0 references

Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis (English)

1 reference

11 August 2017

0 references

1 reference

1 reference

1 reference

B Martin

1

1 reference

11 August 2017

M Paesmans

2

1 reference

11 August 2017

C Mascaux

3

1 reference

11 August 2017

T Berghmans

4

1 reference

11 August 2017

P Lothaire

5

1 reference

11 August 2017

A-P Meert

6

1 reference

11 August 2017

J-J Lafitte

7

1 reference

11 August 2017

J-P Sculier

8

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

91

1 reference

11 August 2017

2018-2025

1 reference

11 August 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602233

11 August 2017

0 references

cites work

The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Comparison of Ki-67 equivalent antibodies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

The Ki-67 protein: from the known and the unknown

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Histopathologic grading of ovarian carcinoma: a review and proposal

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

S-phase fraction and breast cancer--a decade of experience

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Recurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count, and gene protein products.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Method for grading breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Meta-analysis of the literature or of individual patient data: is there a difference?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

The medical review article: state of the science

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Beta blockade during and after myocardial infarction: an overview of the randomized trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Dominoes and clocks: the union of two views of the cell cycle

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

G1 events and regulation of cell proliferation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Review: assessment of cell proliferation in histological material

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Language bias in randomised controlled trials published in English and German.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

C-erbB-2 oncoprotein expression in operable non-small cell lung cancer.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Biological markers in non-small cell lung cancer. Retrospective study of 10 year follow-up after surgery.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Prognostic value of various staging and grading systems in proximal colon cancer

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Proliferation rate of small cell lung carcinoma. A cytomorphometric parameter with prognostic significance

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Low levels of p27 in association with deregulated p53-pRb protein status enhance tumor proliferation and chromosomal instability in non-small cell lung carcinomas.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected nonsmall cell lung carcinoma.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Ploidy, proliferative activity, p53 and bcl-2 expression in bronchopulmonary carcinoids: relationship with prognosis.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409786

Correlation between mitotic and Ki-67 labeling indices in paraffin-embedded carcinoma specimens

24 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602233

Combined analysis of MIB-1 and thyroid transcription factor-1 predicts survival in non-small cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602233

Balance between Cell Division and Cell Death as Predictor of Survival in Patients with Non-Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602233

Blood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602233

[Mulivariate analysis of prognostic factors in non-small cell lung cancer]

21 January 2018

1 reference

12 December 2020

Predicting prognosis in lung cancer: use of proliferation marker, Ki67 monoclonal antibody

1 reference

12 December 2020

[Preliminary study on relationship among apoptosis and related gene, prognosis of lung cancer]

1 reference

12 December 2020

A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers

1 reference

12 December 2020

Tumor cell proliferation in prostate cancer after 3 months of neoadjuvant LHRH analogue treatment is a prognostic marker of recurrence after radical prostatectomy

1 reference

12 December 2020

Prognostic and predictive value of intratumoral microvessels density in operable non-small-cell lung cancer

1 reference

12 December 2020

[VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis]

1 reference

12 December 2020

Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung

1 reference

12 December 2020

Prognostic value of MIB-1 in neuroendocrine tumours of the lung

1 reference

12 December 2020

PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON-SMALL CELL LUNG CANCER

1 reference

12 December 2020

Determination of proliferation index in neoplasms using different Ki-67 equivalent antibodies

1 reference

12 December 2020

[Prognostic factors on surgical treatment for lung cancer]

1 reference

12 December 2020

Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy

1 reference

12 December 2020

Ki-67 immunostaining and survival in operable lung cancer

1 reference

12 December 2020

Ki-67 antigen, a cell cycle and tumor growth marker

1 reference

12 December 2020

Cell-cycle analysis detecting endogenous nuclear antigens: comparison with BrdU-in vivo labeling and an application to lung tumors

1 reference

12 December 2020

Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis

1 reference

12 December 2020

Typical and atypical bronchopulmonary carcinoid tumors: a clinicopathologic and KI-67-labeling study

1 reference

12 December 2020

Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor

1 reference

12 December 2020

Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy

1 reference

12 December 2020

Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count

1 reference

12 December 2020

Molecular biologic substaging of stage I lung cancer according to gender and histology

1 reference

12 December 2020

DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy

1 reference

12 December 2020

Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189

1 reference

12 December 2020

Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung

1 reference

12 December 2020

Biological prognostic factors for early stage completely resected non-small cell lung cancer

1 reference

12 December 2020

Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2

1 reference

12 December 2020

Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers

1 reference

12 December 2020

Useful prognostic panel markers to express the biological tumor status in resected lung adenocarcinomas

1 reference

12 December 2020

[Assessment of metastatic potential of pulmonary carcinoma]

1 reference

12 December 2020

Prognostic implication of Ki-67 immunostaining in treating subclinical pleural cancer found at thoracotomy in lung cancer patients

1 reference

12 December 2020

Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients

1 reference

12 December 2020

High cyclin E and low p27/Kip1 expressions are potentially poor prognostic factors in lung adenocarcinoma patients

1 reference

12 December 2020

[Ki-67, marker of proliferation]

1 reference

12 December 2020

The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6602233

1 reference

11 August 2017

1 reference

11 August 2017

1 reference